Development of genome-wide polygenic risk scores for lipid traits and clinical applications for dyslipidemia, subclinical atherosclerosis, and diabetes cardiovascular complications among East Asians.


Journal

Genome medicine
ISSN: 1756-994X
Titre abrégé: Genome Med
Pays: England
ID NLM: 101475844

Informations de publication

Date de publication:
19 02 2021
Historique:
received: 17 06 2020
accepted: 12 01 2021
entrez: 20 2 2021
pubmed: 21 2 2021
medline: 21 1 2022
Statut: epublish

Résumé

The clinical utility of personal genomic information in identifying individuals at increased risks for dyslipidemia and cardiovascular diseases remains unclear. We used data from Biobank Japan (n = 70,657-128,305) and developed novel East Asian-specific genome-wide polygenic risk scores (PRSs) for four lipid traits. We validated (n = 4271) and subsequently tested associations of these scores with 3-year lipid changes in adolescents (n = 620), carotid intima-media thickness (cIMT) in adult women (n = 781), dyslipidemia (n = 7723), and coronary heart disease (CHD) (n = 2374 cases and 6246 controls) in type 2 diabetes (T2D) patients. Our PRSs aggregating 84-549 genetic variants (0.251 < correlation coefficients (r) < 0.272) had comparably stronger association with lipid variations than the typical PRSs derived based on the genome-wide significant variants (0.089 < r < 0.240). Our PRSs were robustly associated with their corresponding lipid levels (7.5 × 10 The PRSs derived and validated here highlight the potential for early genomic screening and personalized risk assessment for cardiovascular disease.

Sections du résumé

BACKGROUND
The clinical utility of personal genomic information in identifying individuals at increased risks for dyslipidemia and cardiovascular diseases remains unclear.
METHODS
We used data from Biobank Japan (n = 70,657-128,305) and developed novel East Asian-specific genome-wide polygenic risk scores (PRSs) for four lipid traits. We validated (n = 4271) and subsequently tested associations of these scores with 3-year lipid changes in adolescents (n = 620), carotid intima-media thickness (cIMT) in adult women (n = 781), dyslipidemia (n = 7723), and coronary heart disease (CHD) (n = 2374 cases and 6246 controls) in type 2 diabetes (T2D) patients.
RESULTS
Our PRSs aggregating 84-549 genetic variants (0.251 < correlation coefficients (r) < 0.272) had comparably stronger association with lipid variations than the typical PRSs derived based on the genome-wide significant variants (0.089 < r < 0.240). Our PRSs were robustly associated with their corresponding lipid levels (7.5 × 10
CONCLUSIONS
The PRSs derived and validated here highlight the potential for early genomic screening and personalized risk assessment for cardiovascular disease.

Identifiants

pubmed: 33608049
doi: 10.1186/s13073-021-00831-z
pii: 10.1186/s13073-021-00831-z
pmc: PMC7893928
doi:

Substances chimiques

Lipids 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

29

Références

J Am Coll Cardiol. 2018 Oct 16;72(16):1894-1897
pubmed: 30309465
Lancet. 2010 May 8;375(9726):1634-9
pubmed: 20452521
Circ Genom Precis Med. 2020 Apr;13(2):e002725
pubmed: 32154731
PLoS Med. 2020 Jul 28;17(7):e1003209
pubmed: 32722720
Int J Obes (Lond). 2007 Feb;31(2):254-60
pubmed: 16718283
Gigascience. 2015 Feb 25;4:7
pubmed: 25722852
Arterioscler Thromb Vasc Biol. 2013 Sep;33(9):2233-9
pubmed: 23766260
PLoS Genet. 2016 May 26;12(5):e1006078
pubmed: 27227539
Nat Genet. 2018 Sep;50(9):1219-1224
pubmed: 30104762
Curr Opin Lipidol. 2019 Apr;30(2):71-81
pubmed: 30676533
J Am Coll Cardiol. 2012 Dec 25;60(25):2631-9
pubmed: 23083789
Nat Genet. 2017 Dec;49(12):1758-1766
pubmed: 29083408
Eur Heart J. 2015 Mar 1;36(9):539-50
pubmed: 24474739
PLoS Genet. 2009 Nov;5(11):e1000730
pubmed: 19936222
J Epidemiol. 2017 Mar;27(3S):S2-S8
pubmed: 28189464
Am J Hum Genet. 2014 Feb 6;94(2):223-32
pubmed: 24507774
Nat Genet. 2012 Jul 22;44(8):955-9
pubmed: 22820512
Nat Genet. 2016 Oct;48(10):1284-1287
pubmed: 27571263
Nat Genet. 2018 Mar;50(3):390-400
pubmed: 29403010
Pharmacogenomics. 2015;16(12):1387-97
pubmed: 26226939
Diabetologia. 2013 Feb;56(2):298-310
pubmed: 23160641
Nat Genet. 2013 Nov;45(11):1274-1283
pubmed: 24097068
Circ Cardiovasc Genet. 2016 Feb;9(1):37-44
pubmed: 26582766
Lancet. 2012 Aug 11;380(9841):581-90
pubmed: 22607822
Am J Hum Genet. 2012 Nov 2;91(5):823-38
pubmed: 23063622
Clin Chem. 1972 Jun;18(6):499-502
pubmed: 4337382
PLoS One. 2017 Jul 5;12(7):e0179238
pubmed: 28678847
J Am Coll Cardiol. 2019 Jun 25;73(24):e285-e350
pubmed: 30423393
Nat Genet. 2019 Apr;51(4):584-591
pubmed: 30926966
Nature. 2010 Aug 5;466(7307):707-13
pubmed: 20686565
Arch Dis Child. 2007 Mar;92(3):224-8
pubmed: 17088339
PLoS One. 2016 Jan 05;11(1):e0146081
pubmed: 26731281
J Am Coll Cardiol. 2018 Oct 16;72(16):1883-1893
pubmed: 30309464
JAMA Cardiol. 2020 Apr 1;5(4):390-399
pubmed: 32049305
Atherosclerosis. 2005 Apr;179(2):299-304
pubmed: 15777545
Nature. 2015 Oct 1;526(7571):68-74
pubmed: 26432245
Lancet. 2012 Aug 11;380(9841):572-80
pubmed: 22607825
Diabetes Care. 2017 May;40(5):679-686
pubmed: 28279981
Am J Hum Genet. 2015 Oct 1;97(4):576-92
pubmed: 26430803
Nat Genet. 2006 Feb;38(2):218-22
pubmed: 16429159
Nat Commun. 2019 Jul 25;10(1):3328
pubmed: 31346163
N Engl J Med. 2008 Mar 20;358(12):1240-9
pubmed: 18354102
Nat Genet. 2018 Nov;50(11):1514-1523
pubmed: 30275531
Nat Commun. 2018 Aug 23;9(1):3391
pubmed: 30140000
Biometrics. 1988 Sep;44(3):837-45
pubmed: 3203132
Kidney Int. 2019 Jan;95(1):178-187
pubmed: 30415941
Cell. 2019 Apr 18;177(3):587-596.e9
pubmed: 31002795
J Am Coll Cardiol. 2016 Sep 20;68(12):1368-9
pubmed: 27634128

Auteurs

Claudia H T Tam (CHT)

Department of Medicine and Therapeutics, The Chinese University of Hong Kong, Hong Kong, China.
Hong Kong Institute of Diabetes and Obesity, The Chinese University of Hong Kong, Hong Kong, China.
CUHK-SJTU Joint Research Centre in Diabetes Genomics and Precision Medicine, Hong Kong, China.

Cadmon K P Lim (CKP)

Department of Medicine and Therapeutics, The Chinese University of Hong Kong, Hong Kong, China.
Hong Kong Institute of Diabetes and Obesity, The Chinese University of Hong Kong, Hong Kong, China.
CUHK-SJTU Joint Research Centre in Diabetes Genomics and Precision Medicine, Hong Kong, China.

Andrea O Y Luk (AOY)

Department of Medicine and Therapeutics, The Chinese University of Hong Kong, Hong Kong, China.
Hong Kong Institute of Diabetes and Obesity, The Chinese University of Hong Kong, Hong Kong, China.
CUHK-SJTU Joint Research Centre in Diabetes Genomics and Precision Medicine, Hong Kong, China.
Li Ka Shing Institute of Health Sciences, The Chinese University of Hong Kong, Hong Kong, China.

Alex C W Ng (ACW)

Department of Medicine and Therapeutics, The Chinese University of Hong Kong, Hong Kong, China.

Heung-Man Lee (HM)

Department of Medicine and Therapeutics, The Chinese University of Hong Kong, Hong Kong, China.
Hong Kong Institute of Diabetes and Obesity, The Chinese University of Hong Kong, Hong Kong, China.

Guozhi Jiang (G)

Department of Medicine and Therapeutics, The Chinese University of Hong Kong, Hong Kong, China.

Eric S H Lau (ESH)

Department of Medicine and Therapeutics, The Chinese University of Hong Kong, Hong Kong, China.

Baoqi Fan (B)

Department of Medicine and Therapeutics, The Chinese University of Hong Kong, Hong Kong, China.

Raymond Wan (R)

Department of Medicine and Therapeutics, The Chinese University of Hong Kong, Hong Kong, China.

Alice P S Kong (APS)

Department of Medicine and Therapeutics, The Chinese University of Hong Kong, Hong Kong, China.
Hong Kong Institute of Diabetes and Obesity, The Chinese University of Hong Kong, Hong Kong, China.
Li Ka Shing Institute of Health Sciences, The Chinese University of Hong Kong, Hong Kong, China.

Wing-Hung Tam (WH)

Department of Obstetrics and Gynaecology, The Chinese University of Hong Kong, Hong Kong, China.

Risa Ozaki (R)

Department of Medicine and Therapeutics, The Chinese University of Hong Kong, Hong Kong, China.

Elaine Y K Chow (EYK)

Department of Medicine and Therapeutics, The Chinese University of Hong Kong, Hong Kong, China.
Hong Kong Institute of Diabetes and Obesity, The Chinese University of Hong Kong, Hong Kong, China.

Ka-Fai Lee (KF)

Department of Medicine and Geriatrics, Kwong Wah Hospital, Yau Ma Tei, Hong Kong, China.

Shing-Chung Siu (SC)

Diabetes Centre, Tung Wah Eastern Hospital, Causeway Bay, Hong Kong, China.

Grace Hui (G)

Diabetes Centre, Tung Wah Eastern Hospital, Causeway Bay, Hong Kong, China.

Chiu-Chi Tsang (CC)

Diabetes and Education Centre, Alice Ho Miu Ling Nethersole Hospital, Tai Po, Hong Kong, China.

Kam-Piu Lau (KP)

North District Hospital, Sheung Shui, Hong Kong, China.

Jenny Y Y Leung (JYY)

Department of Medicine and Geriatrics, Ruttonjee Hospital, Wan Chai, Hong Kong, China.

Man-Wo Tsang (MW)

Department of Medicine and Geriatrics, United Christian Hospital, Kwun Tong, Hong Kong, China.

Grace Kam (G)

Department of Medicine and Geriatrics, United Christian Hospital, Kwun Tong, Hong Kong, China.

Ip-Tim Lau (IT)

Tseung Kwan O Hospital, Tseung Kwan O, Hong Kong, China.

June K Y Li (JKY)

Department of Medicine, Yan Chai Hospital, Tsuen Wan, Hong Kong, China.

Vincent T F Yeung (VTF)

Centre for Diabetes Education and Management, Our Lady of Maryknoll Hospital, Wong Tai Sin, Hong Kong, China.

Emmy Lau (E)

Department of Medicine, Pamela Youde Nethersole Eastern Hospital, Chai Wan, Hong Kong, China.

Stanley Lo (S)

Department of Medicine, Pamela Youde Nethersole Eastern Hospital, Chai Wan, Hong Kong, China.

Samuel Fung (S)

Department of Medicine and Geriatrics, Princess Margaret Hospital, Lai Chi Kok, Hong Kong, China.

Yuk-Lun Cheng (YL)

Department of Medicine, Alice Ho Miu Ling Nethersole Hospital, Tai Po, Hong Kong, China.

Chun-Chung Chow (CC)

Department of Medicine and Therapeutics, The Chinese University of Hong Kong, Hong Kong, China.

Miao Hu (M)

Department of Medicine and Therapeutics, The Chinese University of Hong Kong, Hong Kong, China.

Weichuan Yu (W)

Department of Electronic and Computer Engineering, The Hong Kong University of Science and Technology, Clear Water Bay, Hong Kong, China.

Stephen K W Tsui (SKW)

School of Biomedical Sciences, The Chinese University of Hong Kong, Ma Liu Shui, Hong Kong, China.

Yu Huang (Y)

School of Biomedical Sciences, The Chinese University of Hong Kong, Ma Liu Shui, Hong Kong, China.

Huiyao Lan (H)

Department of Medicine and Therapeutics, The Chinese University of Hong Kong, Hong Kong, China.
Li Ka Shing Institute of Health Sciences, The Chinese University of Hong Kong, Hong Kong, China.

Cheuk-Chun Szeto (CC)

Department of Medicine and Therapeutics, The Chinese University of Hong Kong, Hong Kong, China.

Nelson L S Tang (NLS)

Li Ka Shing Institute of Health Sciences, The Chinese University of Hong Kong, Hong Kong, China.
Department of Chemical Pathology, The Chinese University of Hong Kong, Hong Kong, China.

Maggie C Y Ng (MCY)

Department of Medicine, Vanderbilt University Medical Center, Nashville, USA.

Wing-Yee So (WY)

Department of Medicine and Therapeutics, The Chinese University of Hong Kong, Hong Kong, China.
Hong Kong Institute of Diabetes and Obesity, The Chinese University of Hong Kong, Hong Kong, China.

Brian Tomlinson (B)

Department of Medicine and Therapeutics, The Chinese University of Hong Kong, Hong Kong, China.
Faculty of Medicine, Macau University of Science and Technology, Taipa, Macau, China.

Juliana C N Chan (JCN)

Department of Medicine and Therapeutics, The Chinese University of Hong Kong, Hong Kong, China.
Hong Kong Institute of Diabetes and Obesity, The Chinese University of Hong Kong, Hong Kong, China.
CUHK-SJTU Joint Research Centre in Diabetes Genomics and Precision Medicine, Hong Kong, China.
Li Ka Shing Institute of Health Sciences, The Chinese University of Hong Kong, Hong Kong, China.

Ronald C W Ma (RCW)

Department of Medicine and Therapeutics, The Chinese University of Hong Kong, Hong Kong, China. rcwma@cuhk.edu.hk.
Hong Kong Institute of Diabetes and Obesity, The Chinese University of Hong Kong, Hong Kong, China. rcwma@cuhk.edu.hk.
CUHK-SJTU Joint Research Centre in Diabetes Genomics and Precision Medicine, Hong Kong, China. rcwma@cuhk.edu.hk.
Li Ka Shing Institute of Health Sciences, The Chinese University of Hong Kong, Hong Kong, China. rcwma@cuhk.edu.hk.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH